Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entero Therapeutics (ENTO)
NASDAQ:ENTO
RESEARCH TOOLSreports
Holding ENTO?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 03, 2024 | James Sapirstein Chairman & Ceo,director | xxxxxxxxxxxxx | $1379 |
| Jul 03, 2024 | Sarah Romano Cfo | xxxxxxxxxxxxx | $664 |
| Apr 03, 2024 | James Sapirstein Chairman & Ceo,director | xxxxxxxxxxxxx | $734 |
| Apr 03, 2024 | Sarah Romano Cfo | xxxxxxxxxxxxx | $317 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,832 | Institution | 0.33% | 3,683 | |
| 4,535 | Institution | 0.14% | 1,542 | |
| 4,535 | Institution | 0.14% | 1,542 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,832 | Institution | 0.33% | 3,683 | |
| 4,535 | Institution | 0.14% | 1,542 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,535 | Institution | 0.14% | 3,220 |
FAQ
Who Owns Entero Therapeutics (ENTO)?
Currently, no data Available
What percentage of Entero Therapeutics (ENTO) stock is held by institutional investors?
Currently, no data Available
What percentage of Entero Therapeutics (ENTO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Entero Therapeutics (ENTO)?
Fidelity Concord Street Trust owns the most shares of Entero Therapeutics (ENTO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.